Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets

Chronic graft-versus-host disease (GVHD) can inflict debilitating tissue injury and puts patients at high risk for death from infections. For several decades, little progress was made in the treatment of chronic GVHD, with no drugs approved by the Food and Drug Administration (FDA) for treating…

http://ift.tt/2E6NZSu